Skip to main content

Advertisement

SpringerLink
Log in

Elevated uric acid, the metabolic syndrome and cardiovascular disease: cause, consequence, or just a not so innocent bystander?

  • Editorial
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

For more than 200 years initially seen as a cause of gout, speaking in a politically correct 21st century term, a disease of the rich and very well nourished people, many experimental and epidemiological studies have associated increased levels of serum uric acid (UA) with the classical components of the metabolic syndrome (MS), type 2 diabetes, and cardiovascular disease [1]. This association with components of the MS is seen even in children and adolescents [2]. The topic of increased UA concentrations, its consequences or associations is getting more important nowadays due to the increments in the prevalence of obesity and the MS in both developed and developing countries.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. A.C. Gagliardi, M.H. Miname, R.D. Santos, Uric acid: a marker of increased cardiovascular risk. Atherosclerosis 202, 11–17 (2009)

    Article  PubMed  CAS  Google Scholar 

  2. E.S. Ford, C. Li, S. Cook, H.K. Choi, Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 115, 2526–2532 (2007)

    Article  PubMed  CAS  Google Scholar 

  3. A.Q. Galvan, A. Natali, S. Baldi et al., Effect of insulin on uric acid excretion in humans. Am. J. Physiol. 268, E1–E5 (1995)

    Google Scholar 

  4. U.M. Khosla, S. Zharikov, J.L. Finch et al., Hyperuricemia induces endothelial dysfunction and vasoconstriction. Kidney Int. 67, 1739–1742 (2005)

    Article  PubMed  Google Scholar 

  5. G. Wu, C.J. Meininger, Nitric oxide and vascular insulin resistance. BioFactors 35, 21–27 (2009)

    Article  PubMed  Google Scholar 

  6. F. Matsuura, S. Yamashita, T. Nakamura, M. Nishida, S. Nozaki, T. Funahashi, Y. Matsuzawa, Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism 47, 929–933 (1998)

    Article  PubMed  CAS  Google Scholar 

  7. I. Fabregat, E. Revilla, A. Machado, Short-term control of the pentose phosphate cycle by insulin could be modulated by the NADPH/NADP ratio in rat adipocytes and hepatocytes. Biochem. Biophys. Res. Commun. 146, 920–925 (1987)

    Article  PubMed  CAS  Google Scholar 

  8. T. Nakagawa, H. Hu, S. Zharikov, K.R. Tuttle, R.A. Short, O. Glushakova, X. Ouyang, D.I. Feig, E.R. Block, J. Herrera-Acosta, J.M. Patel, R.J. Johnson, A causal role for uric acid in fructose-induced metabolic syndrome. Am. J. Physiol. Renal. Physiol. 290, F625–F631 (2006)

    Article  PubMed  CAS  Google Scholar 

  9. G. Reaven, Why a cluster is truly a cluster: insulin resistance and cardiovascular disease. Clin. Chem. 54, 785–787 (2008)

    Article  PubMed  CAS  Google Scholar 

  10. K.L. Chien, M.F. Chen, H.C. Hsu, W.T. Chang, T.C. Su, Y.T. Lee, F.B. Hu, Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin. Chem. 54, 310–316 (2008)

    Article  PubMed  CAS  Google Scholar 

  11. V. Bhole, J.W. Choi, S.W. Kim, M. de Vera, H. Choi, Serum uric acid levels and the risk of type 2 diabetes: a prospective study. Am. J. Med. 123, 957–961 (2010)

    Article  PubMed  CAS  Google Scholar 

  12. T. Wang, Y. Bi, M. Xu, Y. Huang, Y. Xu, X. Li, W. Wang, G. Ning, Serum uric acid associates with the incidence of type 2 diabetes in a prospective cohort of middle-aged and elderly Chinese. Endocrine 40, 109–116 (2011)

    Article  PubMed  CAS  Google Scholar 

  13. J.P. Gonçalves, A. Oliveira, M. Severo, A.C. Santos, C. Lopes, Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine. (2012). Epub ahead of print

  14. M.Y. Desai, R.D. Santos, D. Dalal, J.A. Carvalho, D.R. Martin, J.A. Flynn, K. Nasir, R.S. Blumenthal, Relation of serum uric acid with metabolic risk factors in asymptomatic middle-aged Brazilian men. Am. J. Cardiol. 95, 865–868 (2005)

    Article  PubMed  CAS  Google Scholar 

  15. T. Yang, C.H. Chu, C.H. Bai, S.L. You, Y.C. Chou, W.Y. Chou, K.L. Chien, L.C. Hwang, T.C. Su, C.H. Tseng, C.A. Sun, Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis 220, 525–531 (2012)

    Article  PubMed  CAS  Google Scholar 

  16. S.H. Boutcher, S.L. Dunn, T.E. Gail, J. Freund, Regional adiposity distribution and insulin resistance in young Chinese and European Australian women. Scand. J. Clin. Lab. Invest. 71, 653–657 (2011)

    Article  PubMed  CAS  Google Scholar 

  17. R.D. Santos, Uric acid and cardiovascular disease: how to solve another chicken or egg puzzle. Cardiology 114, 298–299 (2009)

    Article  PubMed  Google Scholar 

  18. C. Iribarren, A.R. Folsom, J.H. Eckfeldt, P.G. McGovern, F.J. Nieto, Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC study. Atherosclerosis risk in communities. Ann. Epidemiol. 6, 331–340 (1996)

    Article  PubMed  CAS  Google Scholar 

  19. R.D. Santos, K. Nasir, R. Orakzai, R.S. Meneghelo, J.A. Carvalho, R.S. Blumenthal, Relation of uric acid levels to presence of coronary artery calcium detected by electron beam tomography in men free of symptomatic myocardial ischemia with versus without the metabolic syndrome. Am. J. Cardiol. 99, 42–45 (2007)

    Article  PubMed  CAS  Google Scholar 

  20. A.D. Liese, H.W. Hense, H. Löwel et al., Association of serum acid with all-cause and cardiovascular disease and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization monitoring trends and determinants in cardiovascular diseases. Epidemiology 10, 391–397 (1999)

    Article  PubMed  CAS  Google Scholar 

  21. M.J. Bos, P.J. Koudstaal, A. Hofman, J.C.M. Witteman, M.M.B. Breteker, Uric acid is a risk factor for myocardial infarction and stroke. Stroke 37, 1503–1507 (2006)

    Article  PubMed  CAS  Google Scholar 

  22. A. Strasak, E. Ruttmann, L. Brant et al., Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83 683 Austrian men. Clin. Chem. 54, 273–284 (2008)

    Article  PubMed  CAS  Google Scholar 

  23. R.J. Johnson, D.H. Kang, D. Feig et al., Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 416, 1183–1190 (2003)

    Article  Google Scholar 

  24. F.J. Nieto, C. Iribarren, M.D. Gross, G.W. Cosmotock, R.G. Cutler, Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis 148, 131–139 (2000)

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lipid Clinic Heart Institute (InCor), University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil

    Raul D. Santos

  2. Unidade Clínica de Lipides InCor, HCFMUSP, Av Dr Eneas C Aguiar 44 Segundo Andar Bloco 2 Sala 4 Cep, São Paulo, 05403-900, Brazil

    Raul D. Santos

Authors
  1. Raul D. Santos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raul D. Santos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Santos, R.D. Elevated uric acid, the metabolic syndrome and cardiovascular disease: cause, consequence, or just a not so innocent bystander?. Endocrine 41, 350–352 (2012). https://doi.org/10.1007/s12020-012-9657-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-012-9657-4

Keywords

Search

Navigation